In April 2025, according to Nanjixiong, innovative medical company restor3d, which focuses on 3D-printed personalized orthopedic implants, announced the completion of a $38 million funding round. This funding will play a crucial role in supporting the launch of four new 3D-printed product lines in 2025 and 2026, further advancing the company’s technological innovation in the orthopedic field.
Since its founding, restor3d has been committed to transforming orthopedic care through data-driven and personalized solutions. CEO and co-founder Kurt Jacobus stated:”Our mission is to restore mobility and improve quality of life through advanced 3D printing technologies and AI-driven design.”
Whether it’s helping patients return to work, enjoy hobbies again, or simply walk without pain, restor3d’s technologies have demonstrated tremendous potential. This funding not only strengthens the company’s market position but also lays a solid foundation for expanding its technological reach and setting new industry standards.
Technology Highlights: Four New 3D-Printed Product Lines
One of the core goals of this funding is to accelerate the development and commercialization of four new 3D-printed orthopedic product lines. These new offerings will integrate restor3d’s proprietary TIDAL technology with cutting-edge design, aiming to improve surgical precision, optimize patient outcomes, and reduce procedural complexity.
About restor3d
restor3d is a medical device company headquartered in North Carolina, USA, specializing in the development of personalized orthopedic implants using 3D printing technology. By combining biomaterials, AI-driven design, and digital health solutions, the company provides customized implants tailored to individual patient needs—such as knee, hip, and ankle systems. Its technology, originating from research at Duke University, is focused on enhancing surgical accuracy and patient recovery outcomes, and has been recognized with multiple patents and FDA approvals.
